{"id":"https://openalex.org/W2020994895","doi":"https://doi.org/10.1111/j.2042-7158.1983.tb02969.x","title":"Anti-inflammatory effects of indomethacin ester incorporated in a lipid microsphere","display_name":"Anti-inflammatory effects of indomethacin ester incorporated in a lipid microsphere","publication_year":1983,"publication_date":"1983-06-01","ids":{"openalex":"https://openalex.org/W2020994895","doi":"https://doi.org/10.1111/j.2042-7158.1983.tb02969.x","mag":"2020994895","pmid":"https://pubmed.ncbi.nlm.nih.gov/6135786"},"language":"en","primary_location":{"id":"doi:10.1111/j.2042-7158.1983.tb02969.x","doi":"https://doi.org/10.1111/j.2042-7158.1983.tb02969.x","is_oa":false,"landing_page_url":"https://doi.org/10.1111/j.2042-7158.1983.tb02969.x","pdf_url":null,"source":{"id":"https://openalex.org/S118304455","display_name":"Journal of Pharmacy and Pharmacology","issn_l":"0022-3573","issn":["0022-3573","2042-7158"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","doyens","jufo-1","medline","norway-1","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Pharmacy and Pharmacology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5108278321","display_name":"Yutaka Mizushima","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I163917720","display_name":"St. Marianna University School of Medicine","ror":"https://ror.org/043axf581","country_code":"JP","type":"education","lineage":["https://openalex.org/I163917720"]}],"countries":["JP"],"is_corresponding":true,"raw_author_name":"Y Mizushima","raw_affiliation_strings":["Department of Internal Medicine, St. Marianna University , 2095, Sugao, Kawasaki, 213","Department of Internal Medicine, St. Marianna University, 2095, Sugao, Kawasaki, 213 Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Internal Medicine, St. Marianna University , 2095, Sugao, Kawasaki, 213","institution_ids":["https://openalex.org/I163917720"]},{"raw_affiliation_string":"Department of Internal Medicine, St. Marianna University, 2095, Sugao, Kawasaki, 213 Japan","institution_ids":["https://openalex.org/I163917720"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Y Wada","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210088742","display_name":"Kowa (Japan)","ror":"https://ror.org/009z2z347","country_code":"JP","type":"company","lineage":["https://openalex.org/I4210088742"]},{"id":"https://openalex.org/I4405276572","display_name":"KOWA Pharmaceutical Company Ltd. (Japan)","ror":"https://ror.org/05q0feg63","country_code":"JP","type":"company","lineage":["https://openalex.org/I4405276572"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Y Wada","raw_affiliation_strings":["Kowa Pharmaceutical Co., Ltd. , Higashimurayama, Tokyo"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Kowa Pharmaceutical Co., Ltd. , Higashimurayama, Tokyo","institution_ids":["https://openalex.org/I4210088742","https://openalex.org/I4405276572"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5066734793","display_name":"Y Etoh","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210088742","display_name":"Kowa (Japan)","ror":"https://ror.org/009z2z347","country_code":"JP","type":"company","lineage":["https://openalex.org/I4210088742"]},{"id":"https://openalex.org/I4405276572","display_name":"KOWA Pharmaceutical Company Ltd. (Japan)","ror":"https://ror.org/05q0feg63","country_code":"JP","type":"company","lineage":["https://openalex.org/I4405276572"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Y Etoh","raw_affiliation_strings":["Kowa Pharmaceutical Co., Ltd. , Higashimurayama, Tokyo"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Kowa Pharmaceutical Co., Ltd. , Higashimurayama, Tokyo","institution_ids":["https://openalex.org/I4210088742","https://openalex.org/I4405276572"]}]},{"author_position":"last","author":{"id":null,"display_name":"K Watanabe","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210088742","display_name":"Kowa (Japan)","ror":"https://ror.org/009z2z347","country_code":"JP","type":"company","lineage":["https://openalex.org/I4210088742"]},{"id":"https://openalex.org/I4405276572","display_name":"KOWA Pharmaceutical Company Ltd. (Japan)","ror":"https://ror.org/05q0feg63","country_code":"JP","type":"company","lineage":["https://openalex.org/I4405276572"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"K Watanabe","raw_affiliation_strings":["Kowa Pharmaceutical Co., Ltd. , Higashimurayama, Tokyo"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Kowa Pharmaceutical Co., Ltd. , Higashimurayama, Tokyo","institution_ids":["https://openalex.org/I4210088742","https://openalex.org/I4405276572"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5108278321"],"corresponding_institution_ids":["https://openalex.org/I163917720"],"apc_list":{"value":2911,"currency":"GBP","value_usd":3839},"apc_paid":null,"fwci":3.7084,"has_fulltext":false,"cited_by_count":38,"citation_normalized_percentile":{"value":0.93005671,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":null,"biblio":{"volume":"35","issue":"6","first_page":"398","last_page":"399"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10920","display_name":"Advanced Drug Delivery Systems","score":0.4309000074863434,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10920","display_name":"Advanced Drug Delivery Systems","score":0.4309000074863434,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10704","display_name":"Advancements in Transdermal Drug Delivery","score":0.32760000228881836,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10678","display_name":"Inflammatory mediators and NSAID effects","score":0.20730000734329224,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/lipid-microspheres","display_name":"lipid microspheres","score":0.9829999804496765},{"id":"https://openalex.org/keywords/anti-inflammatory-activity","display_name":"anti-inflammatory activity","score":0.8960000276565552},{"id":"https://openalex.org/keywords/drug-delivery","display_name":"drug delivery","score":0.6869999766349792},{"id":"https://openalex.org/keywords/sustained-release","display_name":"sustained drug release","score":0.460999995470047}],"concepts":[{"id":"https://openalex.org/C104863432","wikidata":"https://www.wikidata.org/wiki/Q614304","display_name":"Pharmacy","level":2,"score":0.5723339319229126},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4861573874950409},{"id":"https://openalex.org/C161191863","wikidata":"https://www.wikidata.org/wiki/Q199655","display_name":"Library science","level":1,"score":0.3894971013069153},{"id":"https://openalex.org/C556039675","wikidata":"https://www.wikidata.org/wiki/Q771035","display_name":"Traditional medicine","level":1,"score":0.3397752046585083},{"id":"https://openalex.org/C512399662","wikidata":"https://www.wikidata.org/wiki/Q3505712","display_name":"Family medicine","level":1,"score":0.18555757403373718},{"id":"https://openalex.org/C41008148","wikidata":"https://www.wikidata.org/wiki/Q21198","display_name":"Computer science","level":0,"score":0.10347574949264526}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000893","descriptor_name":"Anti-Inflammatory Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D007213","descriptor_name":"Indomethacin","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D007213","descriptor_name":"Indomethacin","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D008055","descriptor_name":"Lipids","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008863","descriptor_name":"Microspheres","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011919","descriptor_name":"Rats, Inbred Strains","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013997","descriptor_name":"Time Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051381","descriptor_name":"Rats","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1111/j.2042-7158.1983.tb02969.x","doi":"https://doi.org/10.1111/j.2042-7158.1983.tb02969.x","is_oa":false,"landing_page_url":"https://doi.org/10.1111/j.2042-7158.1983.tb02969.x","pdf_url":null,"source":{"id":"https://openalex.org/S118304455","display_name":"Journal of Pharmacy and Pharmacology","issn_l":"0022-3573","issn":["0022-3573","2042-7158"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","doyens","jufo-1","medline","norway-1","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Pharmacy and Pharmacology","raw_type":"journal-article"},{"id":"pmid:6135786","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/6135786","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of pharmacy and pharmacology","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9476000070571899,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":3,"referenced_works":["https://openalex.org/W1965416548","https://openalex.org/W2052683768","https://openalex.org/W2095691210"],"related_works":["https://openalex.org/W2008518907","https://openalex.org/W2556625921","https://openalex.org/W2321283964","https://openalex.org/W2416051462","https://openalex.org/W2408130077","https://openalex.org/W3136681855","https://openalex.org/W2411854709","https://openalex.org/W2081452618","https://openalex.org/W2106201323","https://openalex.org/W2137742238"],"abstract_inverted_index":{"Y":[0,2,4],"Mizushima,":[1],"Wada,":[3],"Etoh,":[5],"K":[6],"Watanabe;":[7],"Anti-inflammatory":[8],"effects":[9],"of":[10,19],"indomethacin":[11],"ester":[12],"incorporated":[13],"in":[14],"a":[15],"lipid":[16],"microsphere,":[17],"Journal":[18],"Pharmacy":[20],"and":[21],"Pharmacolo":[22]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}